Every 8-K that Hyperliquid Strategies Inc (PURR) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PURR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PURR filings page.
Hyperliquid Strategies Inc (PURR) entered into Amendment No. 3 to its ChEF Purchase Agreement with Chardan Capital Markets LLC on September 14, 2026. The change affects the pricing of additional common stock sales to Chardan after the first 160,000,000 shares sold under the agreement.
After that threshold, the per-share price in a VWAP Purchase or Intraday VWAP Purchase will equal 98.5% of the VWAP over the relevant period, while an Off-Hour VWAP Purchase will be priced at 97.0% of the VWAP, in each case subject to specified adjustments. Amendment No. 3 supersedes and replaces Amendment No. 2 in full.
Hyperliquid Strategies Inc (PURR) entered into Amendment No. 2 to its ChEF Purchase Agreement with Chardan Capital Markets LLC on September 14, 2026, changing how the per share purchase price of common stock is determined for future sales under that agreement.
For any VWAP Purchase or Intraday VWAP Purchase, the price will now equal 98.5% of the VWAP over the applicable purchase period, and for any Off-Hour VWAP Purchase the price will equal 97.0% of the VWAP over the applicable purchase period, in each case subject to specified adjustments.
Hyperliquid Strategies Inc (symbol PURR) entered into Amendment No. 1 to its ChEF Purchase Agreement with Chardan Capital Markets LLC, increasing the Investor’s Total Commitment from $1.0 billion to $2.5 billion of newly issued common stock, subject to existing terms and limitations.
After the first $1.0 billion of sales under the agreement, the Company may not issue additional shares at a price below $12.02 per share if that would cause cumulative issuances below this price to exceed 42,641,847 shares, which represents 19.99% of common shares outstanding immediately before the Amendment, unless stockholders approve issuances above this Exchange Cap under Nasdaq rules.
Hyperliquid Strategies Inc (PURR) reported results for the fiscal year ended June 30, 2026, highlighting a rapid scale-up of its HYPE-token-focused digital asset treasury model. The company generated $305.5 million in net income, driven largely by $709.9 million in net unrealized gains on HYPE tokens, partially offset by a $169.2 million loss on contributed HYPE at business-combination close, $35.6 million of IPR&D write-offs, and $183.5 million of deferred tax expense.
Total assets reached $2,060.0 million as of June 30, 2026, including $149.9 million in cash and cash-like instruments and $1,904.1 million in HYPE tokens (about 29.28 million tokens at $65.04 each), with no debt and stockholders’ equity of $1,872.9 million. Net asset value increased from $744 million in March 2026 to $1,873 million in June 2026, a 152% rise.
From inception through August 19, 2026, the company raised $646.6 million via a committed equity facility at an average $8.70 per PURR share and deployed $773.4 million to accumulate about 16.5 million additional HYPE tokens at an average cost of $46.77, bringing total HYPE holdings to 29.3 million. It also repurchased roughly 5.8 million PURR shares for $27.8 million. Management positions PURR as the leading public vehicle for gaining capital-efficient exposure to the HYPE ecosystem.
Hyperliquid Strategies Inc. updated compensation arrangements for its chief operating officer and chief executive officer. The company entered an Executive Placement Agreement with SBR Limited, which provides the services of COO Jeroen Nieuwkoop, including $400,000 annual base pay, a target cash bonus equal to 100% of base pay, and eligibility for annual equity awards with a target value of $1,000,000 under the 2025 Equity Incentive Plan.
The COO agreement also grants two initial restricted stock unit awards, each with a target fair value of $1,000,000, and provides severance, health benefit reimbursements, and accelerated equity vesting if terminated without cause or for good reason, with enhanced benefits during a change in control period. Separately, a First Amendment to CEO David Schamis’ employment agreement raises his base salary to $600,000, sets a 100% target bonus, and provides for annual equity awards targeted between $2,000,000 and $3,000,000 per year starting with the fiscal year beginning July 1, 2026.
Hyperliquid Strategies Inc reported results for the third fiscal quarter and nine months ended March 31, 2026, highlighting its transformation into a HYPE-focused digital asset treasury vehicle. As of March 31, 2026, total assets were $809.4 million, including $113.1 million in cash and cash equivalents and $689.0 million in HYPE tokens based on a HYPE price of $36.60, with $743.5 million in stockholders’ equity and no debt.
For the nine months, the Company generated $3.1 million in staking revenue from HYPE holdings and $1.9 million in interest income, but recorded a $165.4 million net loss driven by $64.0 million in net unrealized losses on HYPE tokens, a one-time $35.6 million IPR&D write-off from the legacy Sonnet acquisition, and a $60.5 million increase in deferred tax expense. In the third quarter alone, staking revenue was $2.6 million, interest income $1.0 million, SG&A and R&D expenses $7.2 million, and net profit $152.5 million, primarily from $198.4 million in unrealized gains on HYPE tokens partially offset by a $42.7 million increase in deferred tax expense.
Since inception of its treasury strategy on December 2, 2025, HSI deployed $216.0 million to accumulate approximately 7.3 million HYPE tokens, bringing total HYPE holdings to 20.0 million tokens as of April 29, 2026, and used $10.5 million to repurchase about 3.0 million PURR shares at an average cost of $3.42 per share, while raising $38.4 million in PURR share issuances under a committed equity facility at an average issue price of approximately $6.31 per share. The Company also announced a validator partnership with Unit, completed the disposition of the majority of its legacy bio-tech operations, and emphasized its role as the largest HYPE-focused digital asset treasury vehicle aligned with Hyperliquid’s growth.
Hyperliquid Strategies Inc filed an amended current report to add detailed financial information for its completed business combination with Sonnet BioTherapeutics Holdings, Inc. The amendment supplies Sonnet’s audited financial statements for the fiscal year ended September 30, 2025 and related notes.
The filing also includes unaudited pro forma condensed combined financial statements showing how Hyperliquid and Sonnet’s finances would look on a combined basis as of and for the period ended September 30, 2025. Management emphasizes these pro forma figures are for informational purposes only and are not intended to represent actual or future results.
Hyperliquid Strategies Inc reported its first detailed results since going public, highlighting a balance sheet with $616.7 million in total assets as of December 31, 2025, including $281.9 million in cash and $327.6 million in HYPE tokens (about 12.86 million tokens).
Stockholders’ equity was $589.8 million with no debt. For the six months ended December 31, 2025, the company generated $0.9 million of interest income and $0.5 million of HYPE staking revenue, with $3.5 million of SG&A and R&D expenses, resulting in a $317.9 million net loss.
The loss mainly reflects $262.4 million in unrealized losses on HYPE tokens, a one-time $35.6 million in-process R&D write-off from the legacy Sonnet business and a $17.8 million increase in deferred tax expense. The company deployed $10.5 million to repurchase about 3.0 million PURR shares and $129.5 million to buy roughly 5.0 million additional HYPE tokens, leaving about $125 million in deployable capital plus a $1 billion equity line of credit.